Awareness of Chorea in Huntington's Disease

被引:8
|
作者
Hergert, Danielle C. [1 ,4 ]
Sanchez-Ramos, Juan [2 ]
Cimino, Cynthia R. [3 ]
机构
[1] New Mexico VA Hlth Care Syst, 1501 San Pedro Dr SE,BHCL 116, Albuquerque, NM 87108 USA
[2] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA
[3] Univ S Florida, Dept Psychol, Tampa, FL 33620 USA
[4] Mind Res Network, 1101Yale Blvd NE, Albuquerque, NM 87106 USA
关键词
Anosognosia; basal ganglia; chorea; Huntington's disease; UNAWARENESS; ANOSOGNOSIA; PARKINSONS; MOVEMENTS; DEFICITS;
D O I
10.3233/JHD-190381
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: Anosognosia, or unawareness of illness of deficits, has been observed in Huntington's disease (HD) in relation to motor and cognitive signs and symptoms. Most studies of awareness in HD have used self-report questionnaire methodology rather than asking patients to report on their symptoms in real-time. The two studies in which patients were asked about their chorea in real-time had small sample sizes and only examined patients early in disease progression. Objective: To examine awareness of chorea in real-time in HD patients across a broad range of disease progression. Methods: Fifty HD patients across motor and cognitive impairment severity were asked if they noticed any involuntary movements after completing a simple working memory task used to elicit chorea. A movement disorders specialist rated the presence or absence of chorea while the patients completed the task. Disagreement between the patient and movement disorders specialist's ratings was considered to be an indicator of unawareness. Results: Approximately 46% of patients who exhibited chorea did not report chorea. Eighty-eight percent of participants who acknowledged chorea did not report chorea in all parts of the body that chorea was observed. Conclusions: HD patients demonstrate unawareness of chorea across cognitive and motor sign severity.
引用
收藏
页码:99 / 103
页数:5
相关论文
共 50 条
  • [21] Chorea Associated With Huntington's Disease: To Treat or Not to Treat?
    Jankovic, Joseph
    Roos, Raymund A. C.
    MOVEMENT DISORDERS, 2014, 29 (11) : 1414 - 1418
  • [22] Objective neurophysiologic analysis of chorea in Huntington's Disease
    Reilmann, R
    Kirsten, F
    Quinn, L
    Henningsen, H
    Marder, K
    Gordon, AM
    NEUROLOGY, 2002, 58 (07) : A308 - A308
  • [23] Functional decline due to chorea in Huntington's Disease
    Frank, SA
    Marshall, F
    Plumb, S
    Oakes, D
    Shoulson, I
    Kieburtz, K
    NEUROLOGY, 2004, 62 (07) : A204 - A204
  • [24] Treatment of chorea in Huntington's disease with ropinirole and pramipexole
    Gunzler, S. A.
    Buczek, M.
    MOVEMENT DISORDERS, 2009, 24 : S165 - S165
  • [25] Tetrabenazine treatment for Huntington's disease - Associated chorea
    Ondo, WG
    Tintner, R
    Thomas, M
    Jankovic, J
    CLINICAL NEUROPHARMACOLOGY, 2002, 25 (06) : 300 - 302
  • [26] deutetrabenazine for the treatment of chorea associated with Huntington's disease
    Gupta, Harshit
    Perkins, Wil
    Stark, Cain
    Kikkeri, Sathya
    Kakazu, Juyeon
    Kaye, Adam
    Kaye, Alan
    HEALTH PSYCHOLOGY RESEARCH, 2022, 10 (05): : 1 - 9
  • [27] Pridopidine in treatment of Huntington's disease: beyond chorea?
    Feigin, Andrew
    LANCET NEUROLOGY, 2011, 10 (12): : 1036 - 1037
  • [28] Valbenazine for the treatment of chorea associated with Huntington's disease
    Patino, Jorge
    Furr Stimming, Erin
    Testa, Claudia M.
    Mehanna, Raja
    EXPERT OPINION ON PHARMACOTHERAPY, 2025, 26 (02) : 127 - 132
  • [29] Automated assessment of bradykinesia and chorea in Huntington's disease
    Kotschet, K. E.
    Osborn, S.
    Horne, M. K.
    MOVEMENT DISORDERS, 2014, 29 : S209 - S210
  • [30] Quantitative assessment of chorea and bradykinesia in Huntington's disease
    Wheelock, V
    Tempkin, T
    Rubchinsky, L
    Akkinepali, R
    Henny, R
    Sigvardt, K
    MOVEMENT DISORDERS, 2005, 20 : S10 - S10